Skip to main content
RENALYTIX PLC logo

RENALYTIX PLC — Investor Relations & Filings

Ticker · RENX ISIN · GB00BYWL4Y04 LEI · 213800NTOH3FK3WER551 IL Human health and social work activities
Open in API
Filings indexed 445 across all filing types
Latest filing 2023-04-19 Regulatory Filings
Country GB United Kingdom
Listing IL RENX

About RENALYTIX PLC

https://renalytix.com/

Renalytix is a diagnostics company that develops artificial intelligence-enabled solutions for the clinical management of kidney disease. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized blood test for adults with type 2 diabetes and early-stage chronic kidney disease. The test utilizes a proprietary bioprognostic™ methodology to analyze biomarkers and clinical data, predicting the risk of a progressive decline in kidney function over a five-year period. This risk assessment enables clinicians to identify high-risk patients and implement targeted, guideline-recommended treatments to slow disease progression and improve outcomes.

Recent filings

Filing Released Lang Actions
Real-World Evidence Shows KidneyIntelX™ Utility
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 6476W' and concludes with information provided by 'RNS, the news service of the London Stock Exchange.' This strongly indicates a regulatory news service announcement. The content itself is a press release announcing the 'release of new real-world evidence case studies published in the peer reviewed journal' regarding their product, KidneyIntelX. This is an announcement of new information/data, not a comprehensive periodic report (like 10-K or IR) or a transcript. Since it is a general regulatory announcement distributed via RNS and doesn't fit the specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), the most appropriate classification is the general regulatory filing category.
2023-04-19 English
Positive Data Release at NKF Conference
Regulatory Filings Classification · 98% confidence The document begins with an RNS Number (8895V) and is dated April 12, 2023. It announces that data supportive of KidneyIntelX utility will be presented at the National Kidney Foundation Spring Clinical Meeting. The text is structured as a press release detailing scientific findings and upcoming presentations, rather than being a comprehensive financial report (like 10-K or IR) or a transcript of a call. The presence of the RNS header and the concluding boilerplate text from RNS (the news service of the London Stock Exchange) strongly indicates this is a general regulatory announcement or news release. Since it is not a specific financial report, management change, dividend notice, or proxy material, the most appropriate classification is the general regulatory announcement category, RNS.
2023-04-12 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half Year Report' for Renalytix plc for the period ended December 31, 2022. It contains substantive financial data, including revenue, administrative expenses, net loss, and cash position, as well as management commentary and operational highlights. It is not a mere announcement (RPA) or a certification, but a comprehensive interim financial report. H1 2023
2023-03-30 English
Business Update - Replacement
Regulatory Filings Classification · 99% confidence The document is identified by the header 'RNS Number : 3435U' and concludes with information about RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content itself is a 'Business Update' providing operational and commercial progress (insurance coverage, study results) and references previous disclosures like a 'quarterly earnings call'. This structure—a brief update released via the RNS system, often referencing other filings or calls—is characteristic of a general regulatory announcement that doesn't fit the specific definitions of 10-K, ER, or IR. Since it is a general, timely announcement disseminated through the official regulatory news service (RNS), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such disclosures.
2023-03-27 English
Business Update
Regulatory Filings Classification · 98% confidence The document begins with an RNS Number and is dated March 27, 2023. It provides a 'Business Update' detailing recent achievements, specifically securing insurance coverage (EmblemHealth) for their product KidneyIntelX and referencing prior disclosures from a 'November 2022 quarterly earnings call'. It also mentions real-world evidence data and includes standard forward-looking statements and contact information typical of a regulatory news service release. The presence of 'RNS Number' and the explicit mention that 'This information is provided by RNS, the news service of the London Stock Exchange' strongly indicates this is a regulatory announcement disseminated via the RNS system. Since it is an update on business operations and insurance coverage, and not a full financial report (10-K or IR), a dividend notice (DIV), or a management change (MANG), the most appropriate classification is the general regulatory announcement category, RNS.
2023-03-27 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is very short (3802 characters) and its primary purpose is to announce *when* the company will report its financial results (Second Quarter and First Half Fiscal Year 2023) on March 30, along with details for a conference call/webcast. It is not the actual financial report (ER or IR) itself, nor is it a transcript (CT). This fits the definition of announcing the publication of a report. Since it is a formal announcement via RNS (London Stock Exchange news service), the most appropriate classification is Report Publication Announcement (RPA). If RPA were not available, RNS would be the fallback, but RPA is more specific here.
2023-03-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.